ArticleMultiple sclerosis journal - experimental, translational and clinical
Continuous ofatumumab treatment until the early third trimester in multiple sclerosis with preserved neonatal immunity.
Kenzo Sakurai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.